Last reviewed · How we verify
NCT02287441: VEG1
Feasibility Study to Increase Vegetable Consumption
NA trial testing Tomato in Increase Intake of Vegetables or Tomatoes in 24 participants. Completed in 12 April 2016.
22 May 2015
Quick facts
| Lead sponsor | Clinical Nutrition Research Center, Illinois Institute of Technology |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 24 |
| Start date | 14 November 2014 |
| Primary completion | 22 May 2015 |
| Estimated completion | 12 April 2016 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Tomato
- Raw
Conditions studied
- Increase Intake of Vegetables or Tomatoes — all drugs for Increase Intake of Vegetables or Tomatoes →
- Health — all drugs for Health →
Sponsor
Clinical Nutrition Research Center, Illinois Institute of Technology — full company profile →
Who can join
Adults 25 to 60, any sex, with Increase Intake of Vegetables or Tomatoes or Health. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to determine if differences exist in the total vegetable intake of groups that eat either tomato products versus raw vegetable product.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02287441
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Tomato
Trials testing the same drug.
- NCT04086108 — Relative Oral Bioavailability of GABA From Tomatoes · NA · completed
- NCT03581955 — Identification of New Biomarkers of Banana and Tomato Intake · NA · completed
Other Clinical Nutrition Research Center, Illinois Institute of Technology trials
Trials by the same sponsor.
- NCT06986161 — Optimizing Mango's Glycemic Impact: Investigating Mango Consumption Timing in Prediabetic Individuals · NA · recruiting
- NCT06555952 — MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors · NA · recruiting
- NCT05898217 — Vitamin and Mineral Absorption From Milk and PBMAs · NA · active not recruiting
- NCT05892328 — Watermelon Dose Response Blood Pressure Study · NA · active not recruiting
- NCT05601635 — ButyraGen™, Short Chain Fatty Acids and Gut Microbiome · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02287441 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Clinical Nutrition Research Center, Illinois Institute of Technology
- Last refreshed: 26 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02287441.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing